跳至主要内容
临床试验/NCT00196677
NCT00196677终止1 期

Treatment of Glaucomatous Neuropathy With Food Additives

Future Products Management2 个研究点 分布在 1 个国家目标入组 25 人开始时间: 2005年9月1日最近更新:
适应症
相关药物

试验速览

阶段
1 期
状态
终止
发起方
入组人数
25
试验地点
2
主要终点
Improvement in vision field (Protocol24) in a Humphrey's instrument. Scoring according to the Agis study

研究概览

简要总结

The purpose of this study is to determine if certain food additives are effective in the treatment of glaucoma, improving and reversing the progress of the disease.

详细描述

Glaucomatous neuropathy is a condition that worsens with time causing atrophy of the optic nerve and narrowing of the visual field which may culminate in blindness. The treatment tested in the trial employs certain food additives intended to reverse this pathology.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Single Group
主要目的
Treatment
盲法
Double

入排标准

年龄范围
40 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Stable open angle glaucoma - with equilibrated eye internal pressure
  • Above the age of 50 years and have severe damage that does not progress to the vision field in the upper and lower half. Scoring of the vision field will be made according to the Agis study instructions.

排除标准

  • Eye diseases excluding past cataract operation
  • Allergy to one of the components in the preparation
  • Deterioration in the vision field in the last year
  • Kidney diseases, gastrointestinal (G.I.) tract, liver diseases, coagulation problems and thyroid diseases
  • Persons who take steroids
  • Diabetics or unbalanced hyperglycemia
  • Autoimmune diseases
  • Hypertension (not responding to treatment)
  • Psychiatric treatment with drugs, psychiatric pathologies
  • Pregnancy
  • Ability to take more than 3 pills per day regularly

结局指标

主要结局

Improvement in vision field (Protocol24) in a Humphrey's instrument. Scoring according to the Agis study

次要结局

未报告次要终点

研究者

发起方
Future Products Management
申办方类型
Other

研究点 (2)

Loading locations...

相似试验